Business Description
Patrys Ltd
SIC : 2836
ISIN : AU000000PAB9
Description
Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 PAT-DX1-NP, PAT-DX3, and PAT-LM1. Its main technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody that penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.83 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 12.6 | |||||
| 3-Year FCF Growth Rate | 20.6 | |||||
| 3-Year Book Growth Rate | -34.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.13 | |||||
| 9-Day RSI | 67.63 | |||||
| 14-Day RSI | 61.36 | |||||
| 6-1 Month Momentum % | -62.5 | |||||
| 12-1 Month Momentum % | -57.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.53 | |||||
| Quick Ratio | 5.53 | |||||
| Cash Ratio | 3.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.1 | |||||
| Shareholder Yield % | -0.05 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -69.27 | |||||
| ROA % | -61.41 | |||||
| ROIC % | -270.18 | |||||
| ROC (Joel Greenblatt) % | -570.32 | |||||
| ROCE % | -96.29 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.5 | |||||
| EV-to-EBIT | -1.64 | |||||
| EV-to-EBITDA | -1.64 | |||||
| EV-to-FCF | -3.3 | |||||
| Earnings Yield (Greenblatt) % | -61.01 | |||||
| FCF Yield % | -17.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Patrys Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.002 | ||
| Beta | 2.06 | ||
| Volatility % | 45.83 | ||
| 14-Day RSI | 61.36 | ||
| 14-Day ATR (A$) | 0.000389 | ||
| 20-Day SMA (A$) | 0.00405 | ||
| 12-1 Month Momentum % | -57.14 | ||
| 52-Week Range (A$) | 0.003 - 0.01 | ||
| Shares Outstanding (Mil) | 2,057.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Patrys Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Patrys Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Patrys Ltd Frequently Asked Questions
What is Patrys Ltd(ASX:PAB)'s stock price today?
The current price of ASX:PAB is A$0.01. The 52 week high of ASX:PAB is A$0.01 and 52 week low is A$0.00.
When is next earnings date of Patrys Ltd(ASX:PAB)?
The next earnings date of Patrys Ltd(ASX:PAB) is .
Does Patrys Ltd(ASX:PAB) pay dividends? If so, how much?
Patrys Ltd(ASX:PAB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers